FDA expands authorisation of two monoclonal antibodies for treatment and post-exposure prevention…
Amlanivimab and Etesevimab are monoclonal antibodies that are specifically directed against the spike protein of SARS-CoV-2,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
etesevimab
Lilly India gets nod for restricted EU of monoclonal antibody drugs, bamlanivimab and etesevimab to…
Bamlanivimab and etesevimab together have been authorised under Emergency Use Authorization in the US and select EU countries, for…
Lilly’s bamlanivimab plus etesevimab cut death, hospitalisations for early COVID-19 in Phase…
Results support use of bamlanivimab 700 mg and etesevimab 1400 mg, the dose authorised in the US and several other countries
AbCellera gets EUA from US FDA for its antibody Bamlanivimab, along with Etesevimab for COVID-19
Lilly plans to manufacture more than 250,000 doses of the bamlanivimab and etesevimab therapy throughout Q1 2021, and up to a…